DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Friday.
美股期貨今早高開，其中道指期貨上漲約200點。
Shares of DexCom, Inc. (NASDAQ:DXCM) fell sharply during Friday's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued weak FY24 revenue guidance.
DexCom股份（納斯達克股票代碼：DXCM）在週五美股盤前交易中急劇下跌，公司發佈了二季度業績不及預期的收入結果併發布了薄弱的FY24營收預測。
DexCom reported quarterly earnings of 43 cents per share, which beat the analyst consensus estimate of 39 cents. Quarterly sales came in at $1.004 billion which missed the analyst consensus estimate of $1.036 billion.
DexCom報告二季度每股收益爲0.43美元，超出分析師平均預估的0.39美元。季度銷售額爲10.04億美元，低於分析師預估的10.36億美元。
DexCom sees third-quarter revenue in a range of $975 million to $1 billion, versus the $1.15 billion estimate, and full-year revenue in a range of $4. billion to $4.05 billion, versus the $4.33 billion estimate.
DexCom將第三季度營收預期區間設定在9750萬至10億美元，低於11.5億的市場預估值，並將全年營收預期設定在40億至40.5億美元之間，而市場預估值爲43.3億美元。
DexCom shares dipped 37% to $68.00 in the pre-market trading session.
DexCom股價在盤前交易中下跌了37% 至68.00美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- Zynex, Inc. (NASDAQ:ZYXI) shares declined 21.5% to $8.00 in pre-market trading after the company reported worse-than-expected second-quarter financial results.
- Ur-Energy Inc. (NYSE:URG) shares fell 9.2% to $1.18 in pre-market trading after the company announced a proposed public offering of common shares.
- Tandem Diabetes Care, Inc. (NASDAQ:TNDM) shares declined 9% to $36.99 in pre-market trading. Tandem Diabetes Care will release its second quarter results after the closing bell on Thursday, Aug. 1.
- MacroGenics, Inc. (NASDAQ:MGNX) shares dipped 8.9% to $5.01 in pre-market trading after gaining 5% on Thursday.
- Olin Corporation (NYSE:OLN) shares declined 8.1% to $44.15 in pre-market trading following a second-quarter earnings miss.
- Carter's, Inc. (NYSE:CRI) shares fell 7.4% to $55.40 in pre-market trading following weak quarterly sales.
- Indivior PLC (NASDAQ:INDV) shares fell 4.4% to $12.52 in pre-market trading. Indivior shares jumped 20% on Thursday after the company reported better-than-expected second-quarter financial results and announced an accelerated $100 million share repurchase program.
- Zynex股份（納斯達克股票代碼：ZYXI）在盤前交易中下跌21.5%，至8.00美元，因公司發佈了二季度財務業績低於市場預估值的消息。
- Ur-能源公司（紐交所股票代碼：URG）在盤前交易中下跌了9.2%，至1.18美元，因公司宣佈擬發行普通股。
- Tandem Diabetes Care公司（納斯達克股票代碼：TNDM）在盤前交易中下跌了9%，至36.99美元。公司將在8月1日星期四收盤後發佈第二季度業績。
- MacroGenics股份（納斯達克股票代碼：MGNX）在盤前交易中下跌了8.9%，至5.01美元，之前該公司股價在週四上漲了5%。
- 歐林公司（紐交所股票代碼：OLN）在盤前交易中下跌了8.1%，至44.15美元，因公司二季度收益不及預期。
- Carter's公司（紐交所股票代碼：CRI）在盤前交易中下跌了7.4%，至55.40美元，因公司季度銷售不佳。
- Indivior PLC公司（納斯達克股票代碼：INDV）在盤前交易中下跌了4.4%，至12.52美元。之前該公司發佈了業績優於預期的二季度財務報告，並宣佈了一項加速回購計劃，公司股價週四飆升了20%。
Now Read This:
現在閱讀這個：
- S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
- 標普500、納斯達克破位下跌，科技股持續疲弱：貪婪指數處於“恐懼”區間。
譯文內容由第三人軟體翻譯。